insights_auto
Why is IKT down 6,08%?
Dive Deeperchevron_right
IKT:NASDAQ
Inhibikase Therapeutics Inc
US$1,93
arrow_downward
-6,08%(-0,13) 1D
US$1,98
arrow_upward
+2,59% (+0,050)bedtimeAfter hours
Closed: 1 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
US$2,10
High
US$2,10
Low
US$1,93
Mkt. cap
268,65 ລ້ານ
Avg. vol.
523,64 ພັນ
Volume
476,97 ພັນ
52-wk high
US$2,61
52-wk low
US$1,33
EPS
US$-0,44
Beta
0,95
Shares outstanding
139,54 ລ້ານ
No. of employees
35
Open
US$2,10
High
US$2,10
Low
US$1,93
Mkt. cap
268,65 ລ້ານ
Avg. vol.
523,64 ພັນ
Volume
476,97 ພັນ
52-wk high
US$2,61
52-wk low
US$1,33
EPS
US$-0,44
Beta
0,95
Shares outstanding
139,54 ລ້ານ
No. of employees
35
News stories
From web sources and news partners
WTVB
·
16 ນາທີກ່ອນ
Moderna to join Nasdaq 100, replacing Warner Bros Discovery
OneSafe
·
16 ນາທີກ່ອນ
Evernorth's Nasdaq Arrival Signals a Paradigm Shift in XRP Investment
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
Vylor Takes Corteva’s S&P 500 Seat, Twilio Set To Replace Warner Bros. Discovery — Both Stocks Rise After-Hours
Fox Business
·
3 ຊົ່ວໂມງກ່ອນ
October could be a huge month for the stock market. Here's why.
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, ເດລາແວ, ສະຫະລັດ
SectorBiotechnology
Websiteinhibikase.com